Reginald Reefer’s Top 10 of 2023 – Cannabis Yearly Round up!

As we’re coming to the end of 2023, I think it’s “high time” to create my yearly summary of most important/interesting/viewed cannabis related stories of 2023.

Earlier this year I walked us through the modern history of cannabis, and when I reached this year, I said, “There’s just so much shit that happened this year that I’d write an article about it dedicated to the whole year…”

Well, this is that article.

So here goes Reginald Reefer’s Top 10 of 2023!

P.S – This is in no particular order. That shit is hard to quantify.

STORY 1: Federal Court Rules Gun ban for cannabis users unconstitutional

Kicking off our top ten, we have a big win for civil liberties and cannabis rights. A federal appeals court ruled the federal ban prohibiting cannabis consumers from owning firearms unconstitutional. Judges rejected the Justice Department’s arguments attempting to justify disarming marijuana users as an historical precedent.

The ruling states nothing in 18th or 19th century laws specifically restricted gun ownership for those using intoxicating substances. While laws regulated firearms and intoxicants separately, no legislation singled out substance users for firearm bans.

The court even cited the Founding Fathers’ familiarity growing hemp for practical uses, noting they remained unaware of modern cannabis consumption methods. But this nuance only highlights the absurdity of restricting civil rights around a agricultural product humans cultivated beneficially across centuries.

Especially considering alcohol’s notoriety fueling violence, the opinion states past laws never disarmed regular drinkers later while sober. So even present problematic behaviors like drunk driving remain circumstantial, not blanket justifications for rescinding basic constitutional rights.

The ruling does allow prohibiting intoxicated individuals from immediately possessing guns given temporary impairment concerns. But overall it affirms no sufficient legal grounds exist constricting ownership rights of sober citizens based on extracurricular substance use alone.

This precedent promises immense impact litigation-wise by finally uprooting a stubborn pillar of the drug war threatening owners. It signals the welcome erosion of the thin justifications underpinning prohibition policies from increasingly untenable positions.

While citizens celebrate expanding liberties on one social frontier, global digital frontiers also shift…

Story 2: Twitter (X) becomes first social media platform to allow cannabis businesses to advertise

While expanding rights on one social frontier, the next story profiles a pioneer crossing new digital frontiers – Elon Musk. His Twitter platform made history as the first major social media outlet officially allowing state-legal cannabis companies to advertise.

Contrast this to more puritanical sites still banning cannabis ads despite changing public attitudes. Musk’s maverick move aligns with his disruption of stagnant industries, applying libertarian principles of open commerce and free speech to emerging sectors.

By welcoming this growing cannabis industry onto global communications conduits, Musk catalyzes incredible opportunities while highlighting the silliness of lingering stigma in 2023. We know advertisers will be chomping at the bit to utilize these new channels and that competitors will eventually follow suit.

Once all social platforms inevitability open doors after Twitter’s lead, prepare for an interstellar level marketing war blitzing through screens daily. The cannabis sector just gained prime territory for brand visibility and unprecedented direct customer access almost overnight thanks to unorthodox innovation.

This unpredictable industry liberation perfectly encapsulates Musk himself – a visionary guided by first principles quickly executing what others dismiss as impractical or extreme. His instincts for undervalued ventures produce immense shifts.

And despite some polarizing aspects, Musk consistently foregrounds individual liberty in business and culture above restrictive gatekeeping. This maverick ethos explains the characteristic boldness in welcoming a controversial sector scorned by self-important arbiters of propriety. But the profits will speak volumes.

By empowering enterprise freedom and consumer choice simultaneously with this watershed cannabis move, Musk’s Twitter embodies the frontier spirit crossing boundaries to unlock progress. The ripples from this unprecedented social media brand integration will likely transform economies and attitudes alike.

Speaking of the tragic toll when boundaries overstep in limiting freedoms, our next item also made international headlines.

Story 3: Britney Griner released from Russian Prison for cannabis

Speaking of the unjust toll when laws overstep reasonable boundaries, our next story profiles the harrowing ordeal of basketball icon Brittney Griner. Russian authorities arrested then convicted her of possessing less than 1 gram of cannabis oil through draconian measures. Despite the recent US state-level reforms, Griner’s case illustrated the drastic global legal discrepancies still surrounding the plant that can disrupt lives.

Initially sentenced to nine grueling years in prison, Griner endured nearly a year of harsh penal captivity before returning home through a prisoner exchange deal. But no personal possession amount deserves such disproportionate state coercion disrupting careers and liberty by any ethical standard.

Griner’s high-profile incident encapsulates the ultimate irrationality underpinning any carceral model around consensual adult cannabis use or possession. No practical or moral logic supports incarcerating non-violent individuals for utilizing traditionally safe botanical remedies.

Yet obsolete cultural myths around certain psychoactive flora pervade globally through colonialist residues, sustaining inhumane policies. So while celebrating Griner’s overdue release, the hypocrisy still rings loudly considering America imprisons thousands for equally minor cannabinoid offenses. Vindictive systems profit from this theater measuring “justice”.

The case highlighted truth that until fully embracing enlightened harm reduction regulations, needless suffering persists around ingesting elements of common plants. No healing herbs justify stripping security and community from individuals.

While applauding Griner’s inspirational grace under fire, this injustice spotlights why more citizens reassess the war on human nature pharmaceutically waged upon us without consent. For no happiness should hinge on permission slips for flowers or fungi. Our next story explores this prohibition’s erosion as public opinion cultivates conscientious policy soil.

A new poll reveals most Americans agree the drug war constitutes failed governance requiring urgent overhaul. When even Republicans concur after 50 years of immeasurable costs, the people signal to cease allowing state violence disguising moralism. The tides turn.

Story 4: Massive Study of over 63 million people found cannabis legalization does not lead to increased psychosis diagnoses

A massive new study rebuts a common legalization objection – that increasing cannabis access theoretically promotes psychotic disorders in the population. Prohibitionists often argue this mental health speculation justifies restricting adult access. But groundbreaking data now challenges this narrative.

Recently researchers evaluated a pool of 63 million Medicare recipients over 14 years contrasting psychosis rates and state policy shifts around legalized medical and recreational cannabis. This enormous sample size produced perhaps the most definitive insights to date into this lingering public health concern.

If prohibitionist rhetoric held weight, liberalizing laws expanding cannabis commerce should reveal spikes in related clinical psychosis diagnoses as usage patterns hypothetically shift. But intriguingly, no statistically significant uptick emerged at all across the regions or demographics.

In fact psychotic disorders rates flatlined through the advent of major liberalization reforms. This real-world correlation disputes dire warnings about the dangerous mental health influence of store-bought cannabis. Although paradoxically, no parallel concern exists limiting alcohol linked frequently to psychosis despite its less promising research profile.

While not implying outright cannabis-psychosis causality, the political exploitation of this exaggerated uncertainty to deny adult access faces deep scrutiny now. These latest findings align with prior studies finding no concerning population impact from regulated expansion.

If anything, the robust data suggests improved product quality control and clinical oversight through legal channels optimizes harm reduction over uncontrolled criminalization. And the sheer statistical scope reinforces confidence – over 60 million patient records spanning a decade and half across all states represents authoritative perspective.

This revelations promise profound influence informing future drug policy discussions by deflating a once presumed Achilles’ heel argument against reform. While research continues shedding light, old boogeymen lose teeth rapidly on the march towards national normalization.

Story 5: CDC Study finds cannabis legalization leading to lower teen use

Shifting focus to America’s youth, a promising new CDC study discovered no increase and even declines in teen cannabis use correlated to adult-use legalization reforms. This counterintuitive finding contradicts longtime warnings from prohibitionists insisting state retail expansion would exacerrate youth consumption and addiction rates.

Analyzing extensive federal survey data spanning years before early legalization experiments up through recent times, the trends grew increasingly clear – young cannabis usage has dropped steadily across the board from peak levels in 2009-2013 as more jurisdictions embrace regulated adult-use models.

In fact teen usage rates accelerated their ongoing dip post-2013 when Colorado and Washington first pioneered the state-level adult-use paradigm. This real-world result powerfully refutes rhetoric insisting legal storefronts and advertising would normalize pot smoking among kids.

Across every metric – monthly use, yearly use, lifetime use – the CDC found teenage relationship with cannabis not only failed to intensify but solidified substantial downward shifts in the prohibitionist claimed legalization fallout. This remained consistent even accounting for anomalous pandemic years disrupting substance access through isolation policies.

The credible data aligns with early results from initial legalization pioneer states showing youth use declining despite access expanding for adults. Colorado youth currently use cannabis at lower rates than national averages.

While further study must continue contextualizing multiple influencing societal variables, this CDC analysis importantly demonstrates real-world legalization implementation curtailing underage consumption rather than stoking it.

These insights carry immense weight informing states still fearfully abstaining from reform. As scientifically unfounded worries around promoting youth use dissolve under factual scrutiny, the rationale for delaying aligned public policy weakens further. And communities witness how social openness allows better oversight than blanket demonization.

Story 6: Singapore Executes Man for 2 Pounds of Pot

While legal access progresses domestically, our next disheartening story examines the tragic cost of outdated international prohibition. Despite waves of reform recently washing over even Asian regions, Singapore maintains draconian anti-drug laws including executing citizens caught possessing now mundane amounts of innocuous botanicals like cannabis.

This regressive regime recently took the life of an allegedly non-violent 46-year old Singaporean man convicted of possessing just two pounds of cannabis he planned to distribute. Despite no demonstrated harm or history of prior offenses, he received the death penalty simply for the plant matter contraband charge.

Human rights groups universally decried the disproportionate sentence for a two pound cannabis case. But Singapore officials dismissed criticism of its lethal “zero tolerance” anti-drug stance. The nation stubbornly clings to War on Drugs militant tactics including forced rehabilitation camps and routine execution seemingly impervious to data showing counterproductivity.

The incident sharply contrasts liberalizing attitudes in nearby countries also easing enforcement. While Thailand approved decriminalization last year, Malaysia recently abolished mandatory death penalties for drug charges as global opinion shifts. This makes the continued programmed barbarity by Singapore appear increasingly archaic and backwards by any ethical measure.

By executing a man for two pounds of healing flower pods, the ostensibly modern regime reveals ideological vestiges of colonialism viewing agriculture with spiritual ritual usage as an existential threat warranting ultimate suppression. But such denial of cognitive sovereignty through violence universally backfires by breeding resentment and more dangerous clandestine markets.

One can only hope Singapore soon recognizes the self-sabotage of clinging to disproven militant models against naturally desired plants. But this tragic loss spotlighting unchecked power seeking total coercion cannot be unlived. Perhaps his senseless death nourishes the soil where enlightened drug policy may finally bloom one day in his homeland. For now – darkness.

Our next story eulogizes a differently impactful figure lost recently – the Israeli “Father of THC” Raphael Mechoulam…

Story 7: Death of a Cannabis legend – Dr. Ralph Mechoulam

Shifting from tragedy to tribute, our next item honors the recent passing of Raphael Mechoulam – the pioneering Israeli organic chemist who revolutionized cannabis science through isolating THC and CBD. His research radically transformed global understanding of the plant’s composition and pharmacological mechanisms. All contemporary cannabis medicine owes a debt to his lifetime dedication.

Born 1930 in Bulgaria, Mechoulam immigrated to Israel in 1949 beginning what would become a storied seven decade journey plumbing cannabis’ secrets through exacting lab work. After securing research cannabis from the national police agency in the 1960s, his team successfully identified the previously unknown molecular structure of THC alongside later characterizing CBD.

This profound chemical elucidation single-handedly established the initial pharmacological architecture underlying the cannabis experience. His discoveriespopularized recognizing various cannabinoids and their distinct effects. Every nuggets’s precise psychoactive and medicinal potency today gets credited to Mechoulam’s lifetime cannabis illumination.

Honoring his scientific contributions, Mechoulam received prestigious international accolades including an honorary doctorate from Complutense University in Madrid. The American Chemical Society named the organic cannabinoid pharmacophore after him.

Beyond isolated compounds, Mechoulam helped demonstrate the human body’s innate endocannabinoid system regulating metabolism through sites THC and CBD interact with. This further revolutionized understanding cannabis’ affinity supporting wellness. He authored over 400 published papers cementing his status as the undisputed patriarch of contemporary cannabis academics.

While passing at 92 years old, Mechoulam’s sense of exploration and dedication never waned even into his final years directing an Israeli national cannabinoid research center. His lifetime teachings and mentorship investment ensures successors carry forth trailblazing in this young field. That immortal impact remains Mechoulam’s lasting gift to science – legitimizing and codifying the once taboo frontier of cannabis medicine. Generations further owe their alleviated suffering from this humble giant of organic chemistry done right.

Story 9: Study found that most Parkinson’s Symptoms alleviated with Cannabis use

Shifting focus to uplifting medical advances, our next item profiles cannabis gaining recognition addressing Parkinson’s – a debilitating degenerative nervous system disease confounding solutions for sufferers. But fresh clinical data reveals cannabis components effectively treating common disease symptoms where other treatments fail.

Researchers conducted a retrospective study examining 69 Parkinson’s patients already utilizing state-legal medical cannabis to manage disease burdens. Investigating numerous metrics like symptoms changes, medication changes, side effects and more, a resounding majority – 87% – reported overall improvement from MC addition controlling issues like chronic pain, tremors, and insomnia.

Equally promising, over half the Parkinson’s users also lowered or discontinued conventional medications under medical guidance after adding cannabis – suggesting its comparative efficacy and safety. This aligns with substituted prescription declines in older populations using cannabis for issues like chronic pain management and insomnia.

The accumulating indications powerfully support legal access allowing clinicians responsibly incorporating cannabis alongside traditional modalities as appropriate for given individuals. While more controlled trials are still needed, real-world findings confirm people discover extensive benefit from its anti-inflammatory, analgesic and neuroprotective properties where pharmaceuticals disappoint.

So rather than restricting through outdated cultural stigma, this latest study suggests carefully expanding and personalizing cannabis’s therapeutic utilities may provide a missing treatment puzzle piece for misunderstood conditions like Parkinson’s. Its multifaceted neuromodulatory chemistry further illuminates possibility spaces for intractable neurodegenerative disease.

And that broader healing hope touches our final story in this cannabis journey depicting the changing cultural currents leading inevitably towards sane, compassionate policy honoring this ancient plant ally supporting eons of humankind’s health. But obsolete power constructs currently deny this destiny. Their facade now crumbles.

Story 10: Snoop Dogg Trolls the world

 Our cannabis journey concludes with monumental marketing mischief from the master himself – Snoop Dogg. By tactically tweeting he was mysteriously “quitting smoke” after decades of signature cannabis advocacy, the rap icon tricked global media into reporting his retirement from weed…or so it seemed.

The cryptic tweet instantly made international headlines as outlets rushed obituaries mourning the loss of Snoop’s stoner persona. Twitter exploded in speculation – was it health issues? A religious awakening? Many fans wrote moving tributes eulogizing the career-spanning blunt buffoonery.

But just days later Snoop revealed the ruse in a commercial for a smokeless firepit – he meant tobacco smoke, not bud! The switcheroo wasted no time converting mass publicity into selling Solo Stove’s product. Snoop hadn’t abandoned weed at all – he’d effortlessly finessed free advertising through weaponizing public perception.

In the end, the stunt generated nearly 160 million views on a single tweet containing two sentences. Global engagement metrics rarely seen for any price. And it required no costly media buys – simply leveraging Snoop’s celebrity and grassroots trust for devastating impact.

The marketing masterclass amplified intrigue by cryptically offering just enough dramatic bait before the commercial punchline hit days later. He consciously left the tweet narrative open to grab attention without context before clarifying later.

In actuality, the ploy proved more social commentary on lingering reefer madness stigma than abandoning personal principles. As media rushed demonizing content, it revealed stubborn anti-cannabis biases persisting culturally. Snoop strung them all along easily through minimal smoke and mirrors.

By parodying public cannabis narratives, the saga spotlighted protest prohibitionists’ continued disproportionate influence politicizing plant wisdom without pragmatic perspective. Snoop hoisted detractors on their own faulty petard for profit and activism both. For in destigmatizing justice persists. The maestro wins again.

The Sticky Bottom Line

And there you have it, my selection for the Top Cannabis related articles/stories that had the most impact on society during 2023. There was so much that happened this year that I’m sure I missed a lot, but at the end of the day I believe that these stories held the most weight for the cannabis community.

You know, come to think about it, the woman who stabbed her boyfriend 118 times after the fatal bong rip might also have been worthy, but to be honest, I don’t like to promote that kind of thinking. If you don’t know about that story, it’s pretty messed up.

Anyhow, let me know if there was a news worthy article I missed.

MORE ON THE CANNABIS YEARLY NEWS LEADERS, READ ON…

WHAT WERE THE TOP CANNABIS STORIES OF 2022 AND HOW DID IT GO?